Despite still being technically illegal, the cannabis industry has continued to grow rapidly in North America, with more and more companies going public. In fact, the number of publicly traded cannabis stocks has grown from around 75 in 2014 to over 350 in 2015.
However, while the sector experienced double-digit gains last year, many cannabis stocks have seen share price drops in 2015. As a result, it’s become difficult for investors to decipher which of the many legal cannabis stocks out there are legitimate and which are penny stock scams.
To help cannabis investors better understand what to look for, the Investing News Network spoke with an expert in the space and put together a brief guide on today’s legal cannabis stocks.

What to look for when investing in legal cannabis stocks

As mentioned, the volume of public cannabis stocks in the market has made it difficult to decide which are worth investing in. That’s partially why many stocks are experiencing share price declines despite having great products, teams and assets.
“The main reason cannabis stocks are down is there are no institutional investors,” Derwin Wallace of Cannabis Investor Webcast explained. “There is really no Wall Street involvement, no banks buying the stocks because of federal regulations.”
In other words, looking for cannabis stocks that have cash on hand is a good start. “Cash is my number one metric. If they don’t have any cash, they can’t grow the business,” said Wallace.
Seems simple, doesn’t it? Unfortunately, it’s not always easy to find even basic company information. Wallace explained that because many cannabis stocks are listed on the OTC, they aren’t required to file with the SEC.
“There is a reason they aren’t filing — it could be that they are hiding something, they don’t want you to see something or that they don’t have the money to pay accountants and whatnot. It is a huge red flag,” he noted.
Another metric Wallace said to look at is the number of outstanding shares a company has. If a cannabis stock has a lot of outstanding shares and no revenue, it means that shareholders have little chance of making any money — even if the company eventually does start turning a profit. Other things to look at when choosing a cannabis stock to invest in are liquidity, how many shares are traded per day and outstanding debt.


Management is also important. “You have to look at who is running the company and if they are credible. If you have a pharmaceutical company with a management team with no members with PhDs or doctorates, it doesn’t make much sense, does it?” he quipped.
Furthemore, it’s key to understand that there is an eclectic mix of companies that fit under the “cannabis stocks” banner, from pharmaceutical companies that conduct research, to producers and dispensaries that sell the product to ancillary businesses, including consulting, biotech, real estate, software and security.
“A lot of people think that when we refer to the cannabis space, we are talking about companies that actually touch the plants, either a grower or a dispensary, but it covers a lot more than that,” Wallace said.
Naturally, it’s safer to look at businesses that don’t actually deal with the plants themselves — everything from growing and harvesting equipment, such as lights and fertilizers, to medical containers. Investing in such quasi-cannabis stocks removes the issue of legality completely.
Here is a list of the cannabis stocks and ancillary stocks that Wallace and Technical420 founder Michael Berger believe are worth looking at.

Legal cannabis stock picks

  • Nemus Biosciences (OTCMKTS:NMUS) — A biopharmaceutical company focused on developing and commercializing new chemical entities from cannabinoids.
  • Med-Cannabis Pharma (OTCBB:MCPI) — A company focused on acquiring medical marijuana dispensaries in the US. Currently has three locations in Oregon, where cannabis is legal.
  • Tweed (TSXV:TWD) — A legal medical marijuana company based in Ontario. Tweed is one of the authorized licensed producers under Health Canada’s Marihuana for Medical Purposes Regulations. It recently merged with Bedrocan, another authorized licensed Canadian producer.
  • OrganiGram (TSXV:CGI) — A medical marijuana delivery service for patients and doctors in Canada; also an authorized licensed producer.
  • Mettrum Health (TSXV:MT) — A Canadian cannabis grower also on Health Canada’s authorized licensed producers list.
  • CannLabs (OTCMKTS:CANL) — Full-service cannabis testing lab for both medical and non-medical-grade cannabis products.
  • Pazoo (OTCMKTS:PZOO) — Medical cannabis testing and certification operation in the US.
  • Zynerba Pharmaceuticals (NASDAQ:ZYNE) — A pharmaceutical company looking to develop next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery for patients with significant medical need.
  • Cannabics Pharmaceuticals (OTCMKTS:CNBX) — A US-based cannabis stock focused on developing advanced cannabinoid-based treatments and therapies.

Ancillary cannabis stock picks

These companies have interests in the cannabis sector, but are not focused primarily on the industry and hold interests elsewhere. That means they are often able to avoid legal issues and can operate anywhere.


  • AeroGrow International (OTCMKTS:AERO) — Creator and manufacturer of Miracle-Gro AeroGardens.
  • GW Pharmaceuticals (LSE:GWP,NASDAQ:GWPH) — British biopharmaceutical company known for its cannabinoid medicine Sativex, used for the treatment of spasticity due to multiple sclerosis.
  • Insys Therapeutics (NASDAQ:INSY) — Specialty pharmaceutical company working to develop cannabinoid medicines, such as its inhaled synthetic pharmaceutical cannabinoid products.
  • Heliospectra (OTCMKTS:HLSPY) — LED lighting systems company that creates LED grow lights for greenhouses, indoor growers and researchers.
  • Cafe Serendipity (OTCMKTS:CAFS) — Creating a unique name and brand for the legal cannabis industry.
  • Ambient Water (OTCBB:AWGI) — Formerly AWG International, this company pioneered atmospheric water generation technology for extracting water from humidity in the air.
  • Abbott Laboratories (NYSE:ABT) — Big pharma company with interests in the cannabis space and pharmaceutical products that contain cannabinoids.
  • Blue Line Protection Group (OTCBB:BLPG) — Security company that offers services to cannabis dispensaries.

 
Securities Disclosure: I, Kristen Moran, hold no direct investment interest in any company mentioned in this article.
Related reading: 
How to Invest in Medical Cannabis
Legalizing Medical Cannabis: A Look at the Laws Surrounding Medical Marijuana

 Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aurora Cannabis, Inc. (“Aurora” or the “Company”) (NYSE: ACB) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Aurora securities between February 13, 2020, and September 4, 2020, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/acb .

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

Keep reading... Show less

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less